These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34967054)

  • 1. Mail-out bowel cancer screening: Identifying the behavioural stumbling blocks.
    Myers L; Goodwin BC; Ireland M; March S; Aitken J
    Psychooncology; 2022 May; 31(5):816-823. PubMed ID: 34967054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
    Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
    BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A health action process approach for developing invitee endorsed interventions to increase mail-out bowel cancer screening.
    Myers L; Goodwin B; Ralph N; March S
    Appl Psychol Health Well Being; 2022 Aug; 14(3):776-794. PubMed ID: 35107867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating changes to home bowel cancer screening kits: an end-user perspective study.
    Myers L; Ireland MJ; Viljoen B; Goodwin B
    Cancer Causes Control; 2023 Jul; 34(7):583-594. PubMed ID: 37081155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
    Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
    J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of a call-in centre to deliver colorectal cancer screening in primary care.
    Sewitch MJ; Jiang M; Grad R; Yaffe M; Pavilanis A; Joseph L; Barkun AN; Roper M
    Can Fam Physician; 2013 Dec; 59(12):e550-7. PubMed ID: 24336560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation in bowel screening among men attending abdominal aortic aneurysm screening.
    Quyn AJ; Fraser CG; Rodger J; Digan A; Anderson AS; Steele RJC
    Br J Surg; 2018 Apr; 105(5):529-534. PubMed ID: 29465743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for increasing participation in mail-out colorectal cancer screening programs: a systematic review and meta-analysis.
    Goodwin BC; Ireland MJ; March S; Myers L; Crawford-Williams F; Chambers SK; Aitken JF; Dunn J
    Syst Rev; 2019 Nov; 8(1):257. PubMed ID: 31685010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance.
    Ore L; Hagoel L; Lavi I; Rennert G
    Eur J Cancer Prev; 2001 Jun; 10(3):251-6. PubMed ID: 11432712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust.
    Chambers JA; Callander AS; Grangeret R; O'Carroll RE
    BMC Cancer; 2016 Feb; 16():96. PubMed ID: 26872450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of re-participation in faecal occult blood test- based screening for colorectal cancer.
    Cole SR; Gregory T; Whibley A; Ward P; Turnbull D; Wilson C; Flight I; Esterman A; Young GP
    Asian Pac J Cancer Prev; 2012; 13(12):5989-94. PubMed ID: 23464391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOBT completion in FQHCs: impact of physician recommendation, FOBT information, or receipt of the FOBT kit.
    Davis TC; Arnold CL; Rademaker AW; Platt DJ; Esparza J; Liu D; Wolf MS
    J Rural Health; 2012; 28(3):306-11. PubMed ID: 22757955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding of a negative bowel screening result and potential impact on future symptom appraisal and help-seeking behaviour: a focus group study.
    Barnett KN; Weller D; Smith S; Orbell S; Vedsted P; Steele RJC; Melia JW; Moss SM; Patnick J; Campbell C
    Health Expect; 2017 Aug; 20(4):584-592. PubMed ID: 27414462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
    Murphy CC; Sen A; Watson B; Gupta S; Mayo H; Singal AG
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):278-287. PubMed ID: 31740521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.